Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 5h-imidazo(5,1-a)isoindole-5-ethanol, 6-fluoro-alpha-(trans-4-hydroxycyclohexyl)-, (alphar,5s)-
2. Gdc-0919
3. Trans-4-((1r)-2-((5s)-6-fluoro-5h-imidazo(5,1-a)isoindol-5-yl)-1-hydroxyethyl)cyclohexanol
1. 1402837-78-8
2. Ido-in-7
3. Gdc-0919
4. Navoximod [usan]
5. Navoximod (free Base)
6. Nlg-919
7. 926shl95nc
8. Ro7077339-001
9. Rg6078
10. Rg-6078
11. Ro7077339
12. Ro-7077339
13. 4-[(1r)-2-[(5s)-6-fluoro-5h-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl]cyclohexan-1-ol
14. Trans-4-((1r)-2-((5s)-6-fluoro-5h-imidazo(5,1-a)isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol
15. Trans-4-{(1r)-2-[(5s)-6-fluoro-5h-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl}cyclohexan-1-ol
16. Nlg-919 Navoximod
17. Navoximod [inn]
18. Navoximod (usan/inn)
19. Navoximod [who-dd]
20. Unii-926shl95nc
21. Chembl3989951
22. Chembl4530496
23. Schembl13469854
24. Schembl13469866
25. Schembl15511408
26. Bdbm370551
27. Bdbm370555
28. Ex-a4607
29. Nlg-?919
30. Nlg-?919gdc-0919
31. Hy-18770b
32. S8957
33. Zinc253387955
34. Cs-5088
35. Db15439
36. Us10233190, Example 1484
37. Us10233190, Example 1488
38. Ac-35763
39. D11255
40. Navoximod;gdc-0919;ido-in-7;nlg-1488
41. Q27271481
42. (1r,4r)-4-((r)-2-((s)-6-fluoro-5h-imidazo[5,1- A]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol
43. (1s,4s)-4-((r)-2-((s)-6-fluoro-5h-imidazo[5,1- A]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol
44. 1402836-86-5
45. 5h-imidazo(5,1-a)isoindole-5-ethanol, 6-fluoro-.alpha.-(trans-4-hydroxycyclohexyl)-, (.alpha.r,5s)-
46. 5h-imidazo(5,1-a)isoindole-5-ethanol, 6-fluoro-alpha-(trans-4-hydroxycyclohexyl)-, (alphar,5s)-
47. Trans-4-((1r)-2-((5s)-6-fluoro-5h-imidazo(5,1-a)isoindol-5-yl)-1-hydroxyethyl)cyclohexanol
Molecular Weight | 316.4 g/mol |
---|---|
Molecular Formula | C18H21FN2O2 |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 316.15870608 g/mol |
Monoisotopic Mass | 316.15870608 g/mol |
Topological Polar Surface Area | 58.3 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 416 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
33
PharmaCompass offers a list of Navoximod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Navoximod manufacturer or Navoximod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Navoximod manufacturer or Navoximod supplier.
PharmaCompass also assists you with knowing the Navoximod API Price utilized in the formulation of products. Navoximod API Price is not always fixed or binding as the Navoximod Price is obtained through a variety of data sources. The Navoximod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Navoximod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Navoximod, including repackagers and relabelers. The FDA regulates Navoximod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Navoximod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Navoximod supplier is an individual or a company that provides Navoximod active pharmaceutical ingredient (API) or Navoximod finished formulations upon request. The Navoximod suppliers may include Navoximod API manufacturers, exporters, distributors and traders.
Navoximod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Navoximod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Navoximod GMP manufacturer or Navoximod GMP API supplier for your needs.
A Navoximod CoA (Certificate of Analysis) is a formal document that attests to Navoximod's compliance with Navoximod specifications and serves as a tool for batch-level quality control.
Navoximod CoA mostly includes findings from lab analyses of a specific batch. For each Navoximod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Navoximod may be tested according to a variety of international standards, such as European Pharmacopoeia (Navoximod EP), Navoximod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Navoximod USP).